AJP - Regulatory, Integrative and Comparative Physiology, Vol 263, Issue 3 591-R595, Copyright © 1992 by American Physiological Society

ARTICLES

Both CCK-A and CCK-B/gastrin receptors are present on rabbit vagus nerve

C. W. Lin and T. R. Miller
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064.

Cholecystokinin (CCK) receptors on vagal afferents have been implicated in many of the actions of the brain-gut peptide CCK, including satiety. Autoradiographic studies in rats have demonstrated the presence of CCK-A-type receptors on vagus nerves. However, direct and detailed characterization of this important CCK receptor site has never been reported with membrane-binding techniques. Using 125I-Bolt-on-Hunter-CCK octapeptide (125I-BH-CCK-8) and the recently discovered selective agonists and antagonists of CCK receptors, we have delineated the properties of CCK receptors on rabbit vagus nerve. 125I-BH-CCK-8 binding sites appeared to be homogeneous by the Scatchard analysis, with a dissociation constant of 0.14 nM and a maximum binding of 72 fmol/mg protein. However, competition studies using selective CCK ligands showed that the vagal CCK receptors are heterogeneous. A71378, a selective CCK-A agonist, showed biphasic displacement curves, with the high-affinity portion (less than 10 nM) accounting for approximately 60% and the low-affinity portion for approximately 40%. Competitive binding studies using A63387, a selective CCK-B/gastrin receptor agonist, also showed biphasic displacement curves, with the high-affinity portion (less than 30 nM) at approximately 40% and the low-affinity portion at approximately 60%. Under conditions which selectively examined vagal CCK-A or CCK-B/gastrin receptors, we demonstrated that a number of CCK subtype selective agonists and antagonists possessed similar affinities for the vagal CCK-A and -B/gastrin receptors as those found on the guinea pig pancreas (CCK-A) and cerebral cortex (CCK-B), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				B. J. Wang and Z. J. Cui How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R666 - R678. [Abstract] [Full Text] [PDF]

				M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF]

				S. M. Simasko, J. Wiens, A. Karpiel, M. Covasa, and R. C. Ritter Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1303 - R1313. [Abstract] [Full Text] [PDF]

				A. Shemyakin and L. Kapas L-364,718, a cholecystokinin-A receptor antagonist, suppresses feeding-induced sleep in rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1420 - R1426. [Abstract] [Full Text] [PDF]

				J Borovicka, W Schwizer, G Guttmann, D Hartmann, M Kosinski, C Wastiel, A Bischof-Delaloye, and M Fried Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor Gut, June 1, 2000; 46(6): 774 - 781. [Abstract] [Full Text] [PDF]

				H. Y. Kwon, T.-M. Chang, K. Y. Lee, and W. Y. Chey Vagus nerve modulates secretin binding sites in the rat forestomach Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1052 - G1058. [Abstract] [Full Text] [PDF]